IE

Imran Eba

Partner at Action Potential Venture Capital

Cambridge, Massachusetts

Overview 

Imran Eba is a Partner at Action Potential Venture Capital in Cambridge, Massachusetts, with a strong background in investment management, finance, and business development. He has served on the boards of multiple companies and has made significant investments in the biotech sector, including leading Series A funding for Alpheus Medical. Eba's career highlights include his current role as a Partner at Action Potential Venture Capital and his past experience as a Director at GlaxoSmithKline, where he held various key positions in investment management and business development.

Work Experience 

  • Partner

    2013 - Current

    www.actionpotentialvc.com

  • Board Member

    2022

MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.

Raised $115,120,987.00 from MedTech Innovator.

  • Board Member

    2020

Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.

Raised $30,000,000.00 from BrightEdge Fund, Action Potential Venture Capital, Medtech Convergence Fund, SV Health Investors, OrbiMed, Action Potential Venture Capital, BrightEdge Fund, SV Health Investors, OrbiMed and National Brain Tumor Society.

  • Board Member

    2016

NeuSpera Medical is a manufacturing firm that designs, manufactures, and sells implantable neuromodulation medical devices.

Raised $134,888,888.00 from Action Potential Venture Capital, Treo Ventures, Windham Venture Partners, Vertex Ventures HC and Olympus.

  • Board Member

    2014

Axon Therapies develops a healthcare device with a neuromodulation approach to treat heart failure.

Raised $3,299,999.00 from Deerfield and Action Potential Venture Capital.

  • Board Member

    2013

SetPoint Medical develops novel therapeutics for the treatment of chronic autoimmune conditions.

Raised $344,000,000.00 from Citta Capital, SVE Capital, Shangbay Capital, Gilmartin Capital LLC, New Enterprise Associates, Boston Scientific, Action Potential Venture Capital, Richard King Mellon Foundation and Euclidean Capital.

  • Board Member

    2024

  • Program Advisor

    2019

  • Trustee and Member of the Investment and Finance Committees

    2019 - 2024

Articles About Imran

Relevant Websites